Meeting the Challenges in Manufacturing, Formulation, Delivery and Stability of Final Drug Product
by
Steven Shire
Language: English
Release Date: April 24, 2015
Monoclonal antibodies (MAbs) are currently the major class of protein bio therapeutic being developed by biotechnology and pharmaceutical companies. Monoclonal Antibodiesdiscusses the challenges and issues revolving around development of a monoclonal antibody produced by recombinant DNA technology...